What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on: July 01,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on:July 01,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on: July 01,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on:July 01,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on: August 30,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on:August 30,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on: June 01,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on:June 01,2024

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on: June 12,2024

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on:June 12,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on: June 12,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on:June 12,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on: August 06,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on:August 06,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on: July 04,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on:July 04,2024

Lack of access to affordable, nutritious food puts those with chronic liver disease at a higher risk of death

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainFood insecurity, the limited availability of nutritionally adequate food, is a growing public health concern in the United Sta

Updated on: May 26,2024

Lack of access to affordable, nutritious food puts those with chronic liver disease at a higher risk of death

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainFood insecurity, the limited availability of nutritionally adequate food, is a growing public health concern in the United Sta

Updated on:May 26,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on: July 15,2024

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on:July 15,2024